MacroGenics, Inc. (MGNX): Price and Financial Metrics
MGNX Price/Volume Stats
| Current price | $3.59 | 52-week high | $21.88 |
| Prev. close | $3.55 | 52-week low | $2.95 |
| Day low | $3.47 | Volume | 435,500 |
| Day high | $3.62 | Avg. volume | 1,590,105 |
| 50-day MA | $3.56 | Dividend yield | N/A |
| 200-day MA | $9.39 | Market Cap | 224.85M |
MGNX Stock Price Chart Interactive Chart >
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
MGNX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching MGNX
Want to do more research on Macrogenics Inc's stock and its price? Try the links below:Macrogenics Inc (MGNX) Stock Price | Nasdaq
Macrogenics Inc (MGNX) Stock Quote, History and News - Yahoo Finance
Macrogenics Inc (MGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...